Home

Weili Dai

CIK 1134140 · President · last filed 2026-06-12

Weili Dai is a President who has filed 24 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for ASTH, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$443.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.81B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.81B

Companies

3

Total Filings

24

Lifetime Open-Market Net

-$442.97M

Filer Profile

Reported Address
1668 S. GARFIELD AVENUE
2ND FLOOR
ALHAMBRA, CA 91801
Formerly Known As
Weili Dai & Sehat Sutardja (2005–2007)
DAI WEILI (2001–2005)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ASTH Director 18,188 $38.39 $698.2K $0 3 2026-06-12
Astrana Health, Inc. (AMEH) Delisted Director 3,650 $40.82 $149.0K $0 1 2023-12-18
MRVL 10%+ Owner 17,994,124 $211.50 $3.81B -$442.97M 20 2017-10-20

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 ASTH Grant (A) +4,525 $0 EDGAR
2025-06-13 ASTH Grant (A) +6,449 $0 EDGAR
2024-08-14 ASTH Grant (A) +3,564 $0 EDGAR
2023-12-18 Astrana Health, Inc. (AMEH) Delisted Grant (A) +3,650 $0 EDGAR
2017-10-20 MRVL Sell (S) −949,542 -$17.55M EDGAR
2017-10-13 MRVL Sell (S) −2,849,638 -$52.78M EDGAR
2017-10-11 MRVL Sell (S) −5,455,620 -$100.87M EDGAR
2017-10-04 MRVL Sell (S) −3,685,000 -$68.24M EDGAR
2017-10-02 MRVL Sell (S) −187,790 -$3.38M EDGAR
2017-09-15 MRVL Sell (S) −2,750,000 -$49.07M EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.